Pharmacokinetics of tobramycin in cystic fibrosis.
D000293:Adolescent; D000328:Adult; D000617:Aminoglycosides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000378:metabolism*; D001702:Biopharmaceutics; D001830:Body Surface Area; D001835:Body Weight; D002648:Child; D002675:Child, Preschool; D003404:Creatinine / Q000097:blood; D003550:Cystic Fibrosis / Q000097:blood / Q000378:metabolism*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy; D014031:Tobramycin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003404:Creatinine; D014031:Tobramycin